Serum Complement C3f and Fibrinopeptide A Are Potential Novel Diagnostic Biomarkers for Non-Alcoholic Fatty Liver Disease: A Study in Qingdao Twins
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Complement C3f and Fibrinopeptide A Are Potential Novel Diagnostic Biomarkers for Non-Alcoholic Fatty Liver Disease: A Study in Qingdao Twins
Authors
Keywords
Fatty liver, Twins, Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Biomarkers, Amino acid sequence analysis, Aminotransferases, Database searching, Diagnostic medicine
Journal
PLoS One
Volume 9, Issue 9, Pages e108132
Publisher
Public Library of Science (PLoS)
Online
2014-09-25
DOI
10.1371/journal.pone.0108132
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The discovery and identification of a candidate proteomic biomarker of active tuberculosis
- (2013) Jiyan Liu et al. BMC INFECTIOUS DISEASES
- Proteomic and Lipidomic Signatures of Lipid Metabolism in NASH-Associated Hepatocellular Carcinoma
- (2013) K. Muir et al. CANCER RESEARCH
- Peptides in Low Molecular Weight Fraction of Serum Associated with Hepatocellular Carcinoma
- (2013) Yanming An et al. DISEASE MARKERS
- Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast
- (2013) Aldo Profumo et al. Journal of Proteomics
- Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder
- (2013) Maj Vinberg et al. PSYCHONEUROENDOCRINOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
- (2011) Kohichiroh Yasui et al. Clinical Gastroenterology and Hepatology
- Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease
- (2011) Chaohui Yu et al. JOURNAL OF HEPATOLOGY
- Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis
- (2011) Hsin-Yi Yang et al. NUTRITION
- Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases*
- (2011) Terrance P O'Hanlon et al. ARTHRITIS RESEARCH & THERAPY
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- Non-alcoholic fatty liver disease proteomics
- (2010) Eva Rodríguez-Suárez et al. Proteomics Clinical Applications
- Proteome analysis of biological fluids from autoimmune-rheumatological disorders
- (2010) Lucia De Franceschi et al. Proteomics Clinical Applications
- Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease
- (2009) Lauren N. Bell et al. HEPATOLOGY
- Noninvasive Assessment of Hepatic Steatosis
- (2008) Sameer M. Mazhar et al. Clinical Gastroenterology and Hepatology
- Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels
- (2008) Yusuf Yilmaz et al. HEPATOLOGY
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
- (2008) Anna Ludovica Fracanzani et al. HEPATOLOGY
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management
- (2008) Raj Vuppalanchi et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More